Corrigendum to: “Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results” [JHEP Reports 5 (2019) 101041]
Year: 2024
Type: erratum
Abstract: It has come to our attention that the surname of one of the authors in our publication was misspelled. ‘Alia Hafedi’ should read ‘Alia Hadefi’. We apologise for any inconvenience caused. Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre resultsJHEP ReportsVol. 1Issue 6PreviewInsulin resistance is a core pathophysiological defect underscoring type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD). Both conditions improve with duodenal exclusion surgery. Duodenal mucosal resurfacing (DMR) is an endoscopic intervention developed to treat metabolic disease which has been shown to improve glycaemia in patients with poorly controlled T2DM. Herein, we aimed to further analyse the effects of DMR on hepatic and metabolic parameters in this patient cohort. Full-Text PDF Open Access
Source: JHEP Reports
Institutions: Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Metabolon (United States), University College Hospital, University College London Hospitals NHS Foundation Trust, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Erasmus Hospital, Fractyl (United States), Faculdade de Medicina do ABC, Virginia Commonwealth University
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,900
OpenAlex ID: W4392458588